Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cft7455
2. 2504235-67-8
3. D86mf5h9wj
4. Cft-7455
5. (3s)-3-(6-((4-(morpholin-4-ylmethyl)phenyl)methyl)-2-oxobenzo(cd)indol-1-yl)piperidine-2,6-dione
6. 2,6-piperidinedione, 3-(6-((4-(4-morpholinylmethyl)phenyl)methyl)-2-oxobenz(cd)indol-1(2h)-yl)-, (3s)-
7. (3s)-3-[6-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-2-oxobenzo[cd]indol-1-yl]piperidine-2,6-dione
8. 2,6-piperidinedione, 3-[6-[[4-(4-morpholinylmethyl)phenyl]methyl]-2-oxobenz[cd]indol-1(2h)-yl]-, (3s)-
9. Refchem:1081326
10. (s)-3-(6-(4-(morpholinomethyl)benzyl)-2-oxobenzo[cd]indol-1(2h)-yl)piperidine-2,6-dione
11. Unii-d86mf5h9wj
12. Cemsidomida
13. Cemsidomide [inn]
14. Cft7455; Cemsidomide
15. Cemisidomide (usan/inn)
16. Cemsidomide [usan]
17. Cft 7455
18. Orb1301216
19. Chembl5095227
20. Schembl22549709
21. Schembl29881140
22. Gtpl11961
23. Glxc-26095
24. (s)-cft7455
25. Ex-a6043
26. Nsc840579
27. Akos040758857
28. At41376
29. Nsc-840579
30. Bp-28982
31. Da-51799
32. Ms-28680
33. Hy-144841
34. Cs-0435593
35. D12933
36. En300-43393872
37. F987600
38. (3s)-3-(6-{[4-(morpholin-4-ylmethyl)phenyl]methyl}-2-oxobenz[cd]indol-1(2h)-yl]piperidine-2,6-dione
39. (3s)-3-[6-[[4-(4-morpholinylmethyl)phenyl]methyl]-2-oxobenz[cd]indol-1(2h)-yl]-2,6-piperidinedione
40. (3s)-3-[6-[[4-(morpholinomethyl)phenyl]methyl]-2-oxo-benzo[cd]indol-1-yl]piperidine-2,6-dione
41. (3s)-3-[9-({4-[(morpholin-4-yl)methyl]phenyl}methyl)-3-oxo-2-azatricyclo[6.3.1.0,4,12]dodeca-1(12),4,6,8,10-pentaen-2-yl]piperidine-2,6-dione
| Molecular Weight | 469.5 g/mol |
|---|---|
| Molecular Formula | C28H27N3O4 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 79 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 819 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
84
PharmaCompass offers a list of Cemsidomide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cemsidomide manufacturer or Cemsidomide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cemsidomide manufacturer or Cemsidomide supplier.
A Cemsidomide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cemsidomide, including repackagers and relabelers. The FDA regulates Cemsidomide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cemsidomide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cemsidomide supplier is an individual or a company that provides Cemsidomide active pharmaceutical ingredient (API) or Cemsidomide finished formulations upon request. The Cemsidomide suppliers may include Cemsidomide API manufacturers, exporters, distributors and traders.
Cemsidomide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cemsidomide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cemsidomide GMP manufacturer or Cemsidomide GMP API supplier for your needs.
A Cemsidomide CoA (Certificate of Analysis) is a formal document that attests to Cemsidomide's compliance with Cemsidomide specifications and serves as a tool for batch-level quality control.
Cemsidomide CoA mostly includes findings from lab analyses of a specific batch. For each Cemsidomide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cemsidomide may be tested according to a variety of international standards, such as European Pharmacopoeia (Cemsidomide EP), Cemsidomide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cemsidomide USP).
